Using an in-vitro assay with isolated monocytes, we already demonstrated that tmTNF reverse signalling led to an increased production of IL-10, which was able to predict response to TNFi therapy in RA patients [10]. The gene discussed is IL10; the disease is rheumatoid arthritis.